Evaluation of the Effect of Laser Therapy on Lateral Pterygoid Muscle in Patients With Wilke's Stage I and II Temporomandibular Disorders (TMD): Case Series Study

Launched by CAIRO UNIVERSITY · May 22, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at the effects of laser therapy on a muscle called the lateral pterygoid in patients who have specific types of jaw disorders known as Wilke's stage I and II temporomandibular disorders (TMD). TMD can cause pain and discomfort around the jaw and face, and the researchers want to see if laser therapy can help relieve these symptoms.

To participate in this study, you need to be between the ages of 16 and 50 and diagnosed with one of the targeted TMD stages. You should not have any significant health issues that could affect your jaw, and you must be willing to provide consent to take part. Unfortunately, if you have had previous jaw surgeries, facial fractures, or are receiving other treatments for TMD, you won’t be eligible for this trial. If you do join, you can expect to attend several treatment sessions where you will receive laser therapy and have follow-up visits to check on your progress.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • 1. Patients age between 16-50 years with no sex predilection.
• • 2. Patients who will be free from any systemic diseases that affect temporomandibular joint.
• • 3. Patients who will be diagnosed with wilk's stage I and II temporomandibular disorders (TMD).
• • 4. Patients who will be ready to give informed consent.
• Exclusion Criteria:
• • 1. Patients with previous temporo-mandibular surgeries.
• • 2. Patients with previous facial fracture.
• • 3. Patients who will be under another type of treatment for TMD (e.g., occlusal splints, pharmacological drugs, or head and neck surgery).
• • 4. Patients who will not attend the proposed treatment sessions or follow-up visits.